Software for improved imaging technology is approved for use in clinical study in the US
MedCom GmbH's medical imaging technology, which has been integrated with SpectraCure's IDOSE[®] system, is approved by the Food and Drug Administration (FDA) for use in the clinical study in the US. The integration makes the treatment more efficient and facilitates the process.In December 2021 a development project, partially funded by EU, was completed together with the German company MedCom GmbH. MedComs GmbH´s medical imaging technology was adapted to SpectraCure's IDOSE[®] system. MedCom's medical imaging technology has previously been approved by the FDA. Now, the integration of Medcom'